Switch to:
More From Other Websites
FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License... Mar 29 2017
4:05 pm Amgen announces publication of Phase 2 ALCANTARA study results evaluating the efficacy and... Mar 29 2017
Journal Of Clinical Oncology Publishes Data On BLINCYTO® (Blinatumomab) In High-Risk Patients With... Mar 29 2017
Sanofi Genzyme files preemptive legal strike to protect eczema drug Mar 29 2017
​Amgen to move or cut nearly 500 jobs in Thousand Oaks Mar 28 2017
Amgen Awards Three Golden Tickets for LabCentral Residency Mar 28 2017
Cousins (CUZ) Inks Lease with Amgen at Corporate Center Mar 28 2017
Amgen's Humira Biosimilar Approved in Europe Mar 27 2017
Short Interest Pulls Back in Major Biotechs Mar 27 2017
Google life sciences spinoff soaks up huge space (video) Mar 24 2017
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU Mar 24 2017
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Alliance, General... Mar 24 2017
Amgen Secures EU Approval for Anti-Inflammatory Drug Mar 24 2017
European Commission Approves AMGEVITA™ (Biosimilar Adalimumab) For The Treatment Of Certain... Mar 23 2017
Stock Research Reports for Amgen, Berkshire & Walgreens Mar 23 2017
Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can Mar 23 2017
Biotechs Back in the Doghouse After Failed Rally Mar 23 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK